Table 1 |
|||
|
miRNAs and their targets in breast cancer cells |
|||
|
miRNA |
Target |
Functional pathway |
Reference |
|
|
|||
|
Tumor suppressor miRNAs |
|||
|
miR-206 |
ESR1 |
ER signaling |
|
|
miR-17-5p |
AIB1, CCND1, E2F1 |
Proliferation |
|
|
miR-125a, b |
HER2, HER3 |
Anchorage-dependent growth |
|
|
miR-200 |
BMI1, ZEB1, ZEB2 |
TGF-β signaling |
|
|
let-7 |
H-RAS, HMGA2, LIN28, PEBP1 |
Proliferation, differentiation |
|
|
miR-34a |
CCND1, CDK6, E2F3, MYC |
DNA damage, proliferation |
|
|
miR-31 |
FZD3, ITGA5, M-RIP, MMP16, RDX, RHOA |
Metastasis |
[61] |
|
Oncogenic miRNAs |
|||
|
miR-21 |
BCL-2, TPM1, PDCD4, PTEN, MASPIN |
Apoptosis |
|
|
miR-155 |
RHOA |
TGF-β signaling |
[68] |
|
miR-10b |
HOXD10 |
Metastasis |
[69] |
|
miR-373/520c |
CD44 |
Metastasis |
[79] |
|
|
|||
|
miRNAs and their targets in breast cancer. Several studies have identified altered miRNA expression profiles in breast cancer. The loss of several tumor suppressor miRNAs and overexpression of oncogenic miRNAs leads to loss of regulation of several cellular functions that may be involved in breast cancer pathogenesis. |
|||
|
O'Day and Lal Breast Cancer Research 2010 12:201 doi:10.1186/bcr2484 |
|||